Altimmune to Participate at Two Upcoming Investor Conferences

Rhea-AI Summary

Altimmune (Nasdaq: ALT) has announced its participation in two upcoming investor conferences. The company's management team will be present at the Annual Evercore HealthCONx Conference in Coral Gables, FL on December 3, 2024, featuring a fireside chat at 10:50 a.m. ET, and the Piper Sandler Annual Healthcare Conference in New York, NY on December 4, 2024, with a fireside chat scheduled for 3:30 p.m. ET. Both sessions will be available via webcast through the Events section of Altimmune's website. The team will also be available for one-on-one meetings during these events.

News Market Reaction – ALT

-1.63%

-1.63% Session move

In the trading session that priced this news, ALT declined 1.63%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

GAITHERSBURG, Md., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate and be available for 1x1 meetings at the following investor conferences:

• Annual Evercore HealthCONx Conference (Coral Gables, FL)
  Tuesday, December 3, 2024
  Fireside Chat at 10:50 a.m. Eastern Time

• Piper Sandler Annual Healthcare Conference (New York, NY)
  Wednesday, December 4, 2024
  Fireside Chat at 3:30 p.m. Eastern Time

The sessions will be webcast and can be accessed by visiting the Events section of the Altimmune website.

About Altimmune
Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of obesity and MASH. For more information, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on Twitter

Company Contact:
Greg Weaver
Chief Financial Officer
Phone: 240-654-1450
ir@altimmune.com

Investor Contact:
Lee Roth
Burns McClellan
Phone: 646-382-3403
lroth@burnsmc.com

Media Contact:
Danielle Cantey
Inizio Evoke, Biotech
Phone: 619-826-4657
Danielle.cantey@inizioevoke.com

This press release was published by a CLEAR® Verified individual.

FAQ

When is Altimmune (ALT) presenting at the Evercore HealthCONx Conference 2024?

Altimmune will present at the Evercore HealthCONx Conference on Tuesday, December 3, 2024, at 10:50 a.m. Eastern Time in Coral Gables, FL.

What time is Altimmune's (ALT) presentation at the Piper Sandler Healthcare Conference 2024?

Altimmune will present at the Piper Sandler Healthcare Conference on Wednesday, December 4, 2024, at 3:30 p.m. Eastern Time in New York, NY.

How can investors watch Altimmune's (ALT) conference presentations in December 2024?

Investors can watch the presentations via webcast by visiting the Events section of the Altimmune website.

Will Altimmune (ALT) management be available for individual meetings at the December 2024 conferences?

Yes, Altimmune's management team will be available for one-on-one meetings at both investor conferences.